Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01002326 · ClinicalTrials.gov registry record · NA

Cognitive-Behavioral Therapy for Pediatric Body Dysmorphic Disorder

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
13
Enrollment target

NCT01002326: Completed NA study, sponsored by Massachusetts General Hospital.

NCT01002326 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01002326, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
13 participants
Enrollment target

Study Summary

The purpose of this study is to develop and test the effectiveness of Cognitive-Behavioral Therapy (CBT) for children and adolescents suffering from Body Dysmorphic Disorder.

Interventions

  • BEHAVIORAL Cognitive-Behavioral Therapy

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2009-06
Est. Completion 2015-08
Phase NA
Massachusetts General Hospital

2,032 total trials

What the finished NCT01002326 record still lists

NCT01002326 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Cognitive-Behavioral Therapy is the first listed.

NCT01002326 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01002326 about?

NCT01002326 is a clinical study titled "Cognitive-Behavioral Therapy for Pediatric Body Dysmorphic Disorder". The purpose of this study is to develop and test the effectiveness of Cognitive-Behavioral Therapy (CBT) for children and adolescents suffering from Body Dysmorphic Disorder.

What is the current status of trial NCT01002326?

This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2009-06. Estimated completion is 2015-08.

What interventions are being tested in trial NCT01002326?

The interventions under investigation include: Cognitive-Behavioral Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT01002326?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01002326's enrollment target sits among peer trials

13 1911th of 2000 higher than 88 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03125655 · 13 participants

    Regulation of Inflammatory Genes in Psoriasis

  • NCT03774446 · 13 participants · Phase 2

    Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

  • NCT03830151 · 13 participants · Phase 1

    Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

  • NCT04573231 · 13 participants · Phase 2

    Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01002326, the US trial registry maintained by the National Library of Medicine. NCT01002326 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.